Atherosclerotic risk factors and atherosclerotic postoperative events are associated with low inflammation in abdominal aortic aneurysms

Atherosclerosis

Volumn 235, Issue 2, 2014, Pages 632-641

  Hurks, Rob ^a   Vink, Aryan ^a   Hoefer, Imo E ^a   de Vries, Jean Paul P M ^b   Schoneveld, Arjan H ^a   Schermerhorn, Marc L ^c   den Ruijter, Hester M ^a   Pasterkamp, Gerard ^a   Moll, Frans L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Abdominal aortic aneurysms; Atherosclerosis; Inflammation; Lymphocytes; Vascular disease

Indexed keywords

CHOLESTEROL; GELATINASE B; INTERLEUKIN 6; INTERLEUKIN 8; NEUTROPHIL COLLAGENASE; BIOLOGICAL MARKER;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL; ABDOMINAL AORTA; AORTIC ANEURYSM, ABDOMINAL; BLOOD; COMPLICATION; FOLLOW UP; LYMPHOCYTE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDY;

AGED; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INFLAMMATION; LYMPHOCYTES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84921628685     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.05.928     Document Type: Article

References (49)

1. Forsdahl S.H., Singh K., Solberg S., Jacobsen B.K. Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromso Study, 1994-2001. Circulation 2009, 119:2202-2208.
2. Lederle F.A., Johnson G.R., Wilson S.E., Chute E.P., Littooy F.N., Bandyk D., Krupski W.C., Barone G.W., Acher C.W., Ballard D.J. Prevalence and associations of abdominal aortic aneurysm detected through screening. aneurysm detection and management (ADAM) veterans affairs cooperative study group. Ann Intern Med 1997, 126:441-449.
3. Liapis C.D., Avgerinos E.D., Kadoglou N.P., Kakisis J.D. What a vascular surgeon should know and do about atherosclerotic risk factors. JVasc Surg 2009, 49:1348-1354.
4. Golledge J., Norman P.E. Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors?. Arterioscler Thromb Vasc Biol 2010, 30:1075-1077.
5. Cheuk B.L., Lau S.S., Cheng S.W. Carotid intima-media thickness in patients with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2007, 33:149-153.
6. Palazzuoli A., Gallotta M., Guerrieri G., Quatrini I., Franci B., Campagna M.S., Neri E., Benvenuti A., Sassi C., Nuti R. Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population. Vasc Health Risk Manag 2008, 4:877-883.
7. Simons P.C., Algra A., Bots M.L., Banga J.D., Grobbee D.E., van der Graaf Y. Common carotid intima-media thickness in patients with peripheral arterial disease or abdominal aortic aneurysm: the SMART study. second manifestations of ARTerial disease. Atherosclerosis 1999, 146:243-248.
8. Johnsen S.H., Forsdahl S.H., Singh K., Jacobsen B.K. Atherosclerosis in abdominal aortic aneurysms: a causal event or a process running in parallel? The Tromso study,. Arterioscler Thromb Vasc Biol 2010, 30:1263-1268.
9. Cohen J.R., Sarfati I., Danna D., Wise L. Smooth muscle cell elastase, atherosclerosis, and abdominal aortic aneurysms. Ann Surg 1992, 216:327-330. discussion 30-32.
10. Gregory A.K., Yin N.X., Capella J., Xia S., Newman K.M., Tilson M.D. Features of autoimmunity in the abdominal aortic aneurysm. Arch Surg 1996, 131:85-88.
11. Campbell K.A., Lipinski M.J., Doran A.C., Skaflen M.D., Fuster V., McNamara C.A. Lymphocytes and the adventitial immune response in atherosclerosis. Circ Res 2012, 110:889-900.
12. Hellenthal F.A., Buurman W.A., Wodzig W.K., Schurink G.W. Biomarkers of abdominal aortic aneurysm progression. Part 2: Inflammation. Nat Rev Cardiol 2009, 6:543-552.
13. Kuivaniemi H., Platsoucas C.D., Tilson M.D. Aortic aneurysms: an immune disease with a strong genetic component. Circulation 2008, 117:242-252.
14. Nordon I.M., Hinchliffe R.J., Holt P.J., Loftus I.M., Thompson M.M. Review of current theories for abdominal aortic aneurysm pathogenesis. Vascular 2009, 17:253-263.
15. Brown L.C., Powell J.T. Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. uk small aneurysm trial participants. Ann Surg 1999, 230:289-296. discussion 96-97.
16. Fillinger M. Who should we operate on and how do we decide: predicting rupture and survival in patients with aortic aneurysm. Semin Vasc Surg 2007, 20:121-127.
17. Schermerhorn M. A66-year-old man with an abdominal aortic aneurysm: review of screening and treatment,. JAMA 2009, 302:2015-2022.
18. Schlosser F.J., Tangelder M.J., Verhagen H.J., van der Heijden G.J., Muhs B.E., van der Graaf Y., Moll F.L. Growth predictors and prognosis of small abdominal aortic aneurysms. JVasc Surg 2008, 47:1127-1133.
19. Thompson A.R., Cooper J.A., Ashton H.A., Hafez H. Growth rates of small abdominal aortic aneurysms correlate with clinical events. Br J Surg 2010, 97:37-44.
20. Rijbroek A., Moll F.L., von Dijk H.A., Meijer R., Jansen J.W. Inflammation of the abdominal aortic aneurysm wall. Eur J Vasc Surg 1994, 8:41-46.
21. Hurks R., Hoefer I.E., Vink A., de Vries J.P., Heijmen R.H., Schoneveld A.H., et al. Aneurysm-express: human abdominal aortic aneurysm wall expression in relation to heterogeneity and vascular events - rationale and design. Eur Surg Res 2010, 45:34-40.
22. Moll F.L., Powell J.T., Fraedrich G., Verzini F., Haulon S., Waltham M., et al. Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery. Eur J Vasc Endovasc Surg 2011, 1(41 Suppl):S1-S58.
23. Rose G.A., Blackburn H. Cardiovascular survey methods. Monogr Ser World Health Organ 1968, 56:1-188.
24. Post S., Peeters W., Busser E., Lamers D., Sluijter J.P., Goumans M.J., et al. Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. JVasc Res 2008, 45:244-250.
25. Hellings W.E., Pasterkamp G., Vollebregt A., Seldenrijk C.A., De Vries J.P., Velema E., et al. Intraobserver and interobserver variability and spatial differences in histologic examination of carotid endarterectomy specimens. JVasc Surg 2007, 46:1147-1154.
26. Huisman A., Looijen A., van den Brink S.M., van Diest P.J. Creation of a fully digital pathology slide archive by high-volume tissue slide scanning. Hum Pathol 2010, 41:751-757.
27. de Jager W., te Velthuis H., Prakken B.J., Kuis W., Rijkers G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003, 10:133-139.
28. de Kleijn D.P., Moll F.L., Hellings W.E., Ozsarlak-Sozer G., de Bruin P., Doevendans P.A. Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events. Arterioscler Thromb Vasc Biol 2010, 30:612-619.
29. Bobryshev Y.V., Lord R.S., Parsson H. Immunophenotypic analysis of the aortic aneurysm wall suggests that vascular dendritic cells are involved in immune responses. Cardiovasc Surg 1998, 6:240-249.
30. Koch A.E., Haines G.K., Rizzo R.J., Radosevich J.A., Pope R.M., Robinson P.G., Pearce W.H. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990, 137:1199-1213.
31. Bhatt D.L., Steg P.G., Ohman E.M., Hirsch A.T., Ikeda Y., Mas J.L., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006, 295:180-189.
32. Shantikumar S., Ajjan R., Porter K.E., Scott D.J. Diabetes and the abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2010, 39:200-207.
33. Lederle F.A., Johnson G.R., Wilson S.E., Chute E.P., Hye R.J., Makaroun M.S., et al. The aneurysm detection and management study screening program: validation cohort and final results. aneurysm detection and management veterans affairs cooperative study investigators. Arch Intern Med 2000, 160:1425-1430.
34. Iribarren C., Darbinian J.A., Go A.S., Fireman B.H., Lee C.D., Grey D.P. Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study. Ann Epidemiol 2007, 17:669-678.
35. Schlosser F.J., Vaartjes I., van der Heijden G.J., Moll F.L., Verhagen H.J., Muhs B.E., et al. Mortality after elective abdominal aortic aneurysm repair. Ann Surg 2010, 24:1125-1130.
36. Virmani R., Kolodgie F.D., Burke A.P., Farb A., Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000, 20:1262-1275.
37. Kojima S., Maruyoshi H., Nagayoshi Y., Kaikita K., Sumida H., Sugiyama S., et al. Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque. Int J Cardiol 2011, 147:371-376.
38. Parums D.V., Brown D.L., Mitchinson M.J. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 1990, 114:383-387.
39. Parums D.V., Chadwick D.R., Mitchinson M.J. The localisation of immunoglobulin in chronic periaortitis,. Atherosclerosis 1986, 61:117-123.
40. Sweeting M.J., Thompson S.G., Brown L.C., Powell J.T. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg 2012, 99:655-665.
41. Johnston S.L., Lock R.J., Gompels M.M. Takayasu arteritis: a review. JClin Pathol 2002, 55:481-486.
42. Chieh J.J., Brevetti L.S., Scholz P.M., Graham A.M., Ciocca R.G., et al. Multiple isolated aneurysms in a case of "burned out" Takayasu aortitis. JVasc Surg 2003, 37:1094-1097.
43. Rose A.G., Dent D.M. Inflammatory variant of abdominal atherosclerotic aneurysm. Arch Pathol Lab Med 1981, 105:409-413.
44. Wilson W.R., Anderton M., Schwalbe E.C., Jones J.L., Furness P.N., Bell P.R., et al. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation 2006, 113:438-445.
45. Hurks R., Pasterkamp G., Vink A., Hoefer I.E., Bots M.L., van de Pavoordt H.D., et al. Circumferential heterogeneity in the abdominal aortic aneurysm wall composition suggests lateral sides to be more rupture prone. JVasc Surg 2012, 55:203-209.
46. Schermerhorn M.L., Bensley R.P., Giles K.A., Hurks R., O'Malley A.J., Cotterill P., et al. Changes in abdominal aortic aneurysm rupture and short-term mortality, 1995-2008: a retrospective observational study. Ann Surg 2012, 256:651-658.
47. Kotze C.W., Menezes L.J., Endozo R., Groves A.M., Ell P.J., Yusuf S.W. Increased metabolic activity in abdominal aortic aneurysm detected by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). Eur J Vasc Endovasc Surg 2009, 38:93-99.
48. Reeps C., Essler M., Pelisek J., Seidl S., Eckstein H.H., Krause B.J. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. JVasc Surg 2008, 48:417-423.
49. Osborn E.A., Jaffer F.A. The advancing clinical impact of molecular imaging in CVD. JACC Cardiovasc Imaging 2013, 6:1327-1341.